VHL and nonpapillary renal cell carcinoma: Moreover, Nguyen-Tran et al. reported that Oncostatin M (OSM), secreted by VHL-deficient renal cells, activates endothelial cells (ECs), which then promote inflammation and tumorigenesis in the development of ccRCC [21].